Definiens AG, one of the major players in the fast-growing market for digital pathology, raised $12.8 million in additional capital funding. The company, based in Munich, Germany, manufacturers systems for digital image analysis. Definiens stated that the new funds will be used for “commercial expansion of its current business and to develop and commercialize innovative …
October 8, 2012 “Intelligence: Late Breaking Lab News” Read More »
